ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: 2093 • ACR Convergence 2025

    Association of Acetaminophen Use with Clinical Outcomes in Older Adults with Osteoarthritis: A Global Propensity-Matched Retrospective Cohort Analysis

    Justin Riley Lam1, Laith Alomari2, Emmanuel Otabor2, Michael Hamilton2, Bal Subedi3, Maxim Barnett2, Fabian Rodriguez Quinonez4 and Irene Tan5, 1Albert Einstein Medical Center, Philadelphia, PA, 2Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 3Jefferson Einstein Montogmery Hospital, Philadelphia, 4Einstein Medical Center Philadelphia, Philadelphia, PA, 5Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Acetaminophen is widely recommended for osteoarthritis (OA) pain management due to its perceived safety profile. However, its long-term effects on clinical outcomes among older…
  • Abstract Number: 1736 • ACR Convergence 2025

    Multi-Model Evaluation of the Impact of CD14 on Synovial Inflammation and Pain During PTOA.

    Kevin Burt1, Sanique South2, Natalie Adamczyk3, Shingo Ishihara3, Vu Nguyen4, Robert Mauck4, Anne-Marie Malfait5, Timothy Griffin6, Rachel Miller7 and Carla Scanzello1, 1University of Pennsylvania, Philadelphia, PA, 2University of Oregon, Eugene, 3Rush University, Chicago, 4University of Pennsylvania, Philadelphia, 5Rush University, Oak Park, IL, 6Oklahoma Medical Research Foundation, Oklahoma City, 7Rush University Medical Center, Chicago, IL

    Background/Purpose: Soluble CD14, a co-receptor of inflammatory toll-like receptor signaling that is produced primarily by monocytes/macrophages, is present in synovial fluid in patients with OA…
  • Abstract Number: 1249 • ACR Convergence 2025

    Association between Positive Emotions and Physical Function in Early Rheumatoid Arthritis Patients

    Burcu Aydemir1, Jing Song2, Lutfiyya muhammad1, Dorothy Dunlop3, Rowland Chang1, Wendy Marder4, Kevin Deane5, Clifton Bingham6, Vivian Bykerk7, Robert Edwards8, Judy Moskowitz1 and Yvonne Lee9, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Worthington, MN, 3Northwestern University Feinberg School of Medicine, Chicago, 4University of Michigan, Ann Arbor, MI, 5University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 6Johns Hopkins University, Baltimore, MD, 7Hospital For Special Surgery, New York, NY, 8Brigham and Women's Hospital & Harvard Medical School, Boston, MA, 9Northwestern University, Chicago, IL

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that can significantly impair physical function and quality of life. While physical symptoms such as joint…
  • Abstract Number: 1228 • ACR Convergence 2025

    Transcending barriers to pain care in rural America: a pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain

    Brennan Spiegel1, Jeffrey Curtis2, Yashar Eshraghi3, Maged Guirguis3, Beth Darnall4, Christine Rini5, Emily Holladay6, Mehra Muskaan1, So Yung Choi1 and Samuel Eberlein1, 1Cedars Sinai, Los Angeles, CA, 2Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, 3University of Queensland Ochsner Medical School, New Orleans, LA, 4Stanford University School of Medicine, Palo Alto, CA, 5Northwestern University, Chicago, IL, 6University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Evidence-based behavioral treatments for chronic pain are largely inaccessible, particularly to rural patients. This decentralized randomized controlled trial compared the effectiveness of two digital,…
  • Abstract Number: 0813 • ACR Convergence 2025

    Impact of Tirzepatide on Musculoskeletal Pain and High-Risk Analgesic Use Among Non-Diabetic Patients with Overweight or Obesity: A Propensity Score-Matched, Active Comparator, New User Study

    Gregory Challener1, Kevin Sheng-Kai Ma2, Natalie McCormick3, Minna Kohler4, Janeth Yinh3, Chio Yokose5, Sharan Rai6, Florence Porterfield7, Fatima Stanford8, Dong Wook Kim9, April Jorge3 and Hyon K. Choi10, 1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, 2Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States, Philadelphia, PA, 3Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Massachusetts General Hospital, Waltham, MA, 6Massachusetts General Hospital/Harvard Medical School, Boston, MA, 7Division of Endocrinology, Massachusetts General Hospital, Boston, 8Neuroendocrine Unit, Pediatric Endocrinology, Massachusetts General Hospital, Boston, 9Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Boston, 10MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: Tirzepatide is a dual GIP/GLP-1 receptor co-agonist approved for weight loss in patients with obesity or body mass index (BMI) > 27 kg/m2 with…
  • Abstract Number: 0320 • ACR Convergence 2025

    Transcriptomic profiling of the skeletal muscle of knee OA patients uncovers elevated glucocorticoid and GABA signaling as mediators of skeletal muscle dysfunction in advanced disease

    Gina Many1, Tyler Mansfield2, Tyler Sagendorf3, Daniel Evans2, Sameneh Farsijani4, Bret Goodpaster5, Lauren Sparks5 and NANCY LANE6, 1Pacific Northwest National Laboratory, Richland, WA, Richland, WA, 2California Pacific Medical Research Institute, San Francisco, CA, 3Pacific Northwest National Laboratory, Richland, WA, 4University of Pittsburgh, Pittsburgh, PA, 5Translational Research Institute, AventHealth, Orlando, FL, 6University of California at Davis, School of Medicine, Sacramento, CA

    Background/Purpose: Age-related declines in muscle mass and function are leading causes for hospitalizations and mortality in elderly individuals. The risk of developing knee osteoarthritis also…
  • Abstract Number: 2683 • ACR Convergence 2025

    Association of Genetic Risk for Pain Intensity with Longitudinal Disease Activity in Rheumatoid Arthritis

    Stevie Barry1, Katie McMenamin2, Austin Wheeler3, Bryant England3, Grant Cannon4, Brian Sauer5, Gary Kunkel6, Katherine Wysham7, Beth Wallace8, Andreas Reimold9, Gail Kerr10, Isaac Smith11, John Richards12, Iris Lee13, Rui Xiao1, Sylvanus Toikumo14, Henry Kranzler14, Rachel Kember14, Scott Damrauer14, Michael Levin14, Michael George1, Ted Mikuls3, Joshua Baker1 and Thomas Riley1, 1University of Pennsylvania, Philadelphia, PA, 2Boston Medical Center, Boston, MA, 3University of Nebraska Medical Center, Omaha, NE, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 7VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 8Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 9Dallas VA Medical Center, Dallas, TX, 10Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 11Duke University Hospital, Durham, NC, 12Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 13Washington University in St Louis, Saint Louis, MO, 14University of Pennsylvania / Corporal Michael J. Crescenz VAMC, Philadelphia, PA

    Background/Purpose: Guidelines recommend the use of composite scores to evaluate disease activity in RA and inform a treat-to-target approach. It is recognised that patient-reported components…
  • Abstract Number: 2090 • ACR Convergence 2025

    Don’t Throw Out X-Rays! Radiographic Osteoarthritis Severity is Prognostic for Onset of Frequent Knee Pain

    Grace Lo1, Julieann Patarini2, Timothy McAlington3, Charles Eaton4 and Jeffrey Driban5, 1Baylor College of Medicine / MEDVAMC, Houston, TX, 2UMass Chan Medical School, Worcester, MA, 3UMass Chan School of Medicine, Arlington, MA, 4Brown University, Pawtucket, RI, 5University of Massachusetts Chan Medical School, Marlborough, NH

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, a condition associated with substantial disability. Radiographic severity of OA is associated with the presence…
  • Abstract Number: 1735 • ACR Convergence 2025

    Endocrine Disruptors Exacerbates Osteoarthritis Pain And Inflammation

    Elise Herardot1, Nadine Soliman1, Audrey Pigenet1, Ilana Slotine1, Anni Herranan2, Samia Bahieddine1, Jean-Baptiste Fini2, Olivier Tabary1, Adeline Cambon3, Xavier HOUARD4, Francis BERENBAUM5, SELLAM JEREMIE6 and Alice Courties7, 1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France, Paris, France, 2UMR 7221, Phyma, CNRS–Muséum National d’Histoire Naturelle, Sorbonne Université, 75005 Paris, France, Paris, France, 3Department of Orthopedic, Trauma and Hand Surgery, Hôpital Saint-Antoine, Sorbonne University, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France, Paris, France, 4Centre de Recherche Saint-Antoine, UMR_S938 INSERM /Sorbonne Université, Paris, France, PARIS, France, 5Sorbonne University/Inserm/AP-HP/4Moving Biotech, Paris, France, 6Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France, /Rheumatology Department, AP-HP Saint-Antoine Hospital, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France., Paris, France, 7Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012, Paris, France / Rheumatology Department, AP-HP Saint-Antoine Hospital, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France, Paris, France

    Background/Purpose: Osteoarthritis (OA) affects over 590 million individuals globally. Epidemiological data suggest that exposure to environmental pollutants, particularly endocrine-disrupting chemicals (EDCs) such as phthalates, PFAS,…
  • Abstract Number: 1246 • ACR Convergence 2025

    Myo Vs. Myo-fascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial

    seda yildiz1, bugra ince1 and Halil ibrahim candal2, 1izmir sehir hastanesi, izmir, Turkey, 2ızmir sehir hastanesi, izmir

    Background/Purpose: Experimental and clinical studies suggest that fascial structures play a critical role in the pathogenesis and pain mechanisms of myofascial pain syndrome (MTrP). It…
  • Abstract Number: 1227 • ACR Convergence 2025

    The Composition of Circulating Immune Cells is Associated with Nociplastic Pain in Patients with Rheumatoid Arthritis

    Tyler Therron1, Meghan Mayer2, Cecilia Stumpf3, Gelis Galarcé Lugo4, Morgan Langereis5, Kathleen Aren6, Mary Carns5, Cally Mills5, Cheol Min Lee7, Vanessa Manada De Lobos2, Carla Marie Cuda5, Yvonne Lee5 and Deborah Rachelle Winter8, 1Northwestern Feinberg School of Medicine, Chicago, IL, 2Northwestern University, Chicago, 3Northwestern University, Elmhurst, IL, 4Northwestern University Feinberg School of Medicine, Zionsville, IN, 5Northwestern University, Chicago, IL, 6Northwestern University Division of Rheumatology, Chicago, IL, 7Northwestern University Feinberg School of Medicine, Chicago, IL, 8Northwestern University, Skokie, IL

    Background/Purpose: Over half of patients with RA report clinically meaningful pain, despite treatment with disease-modifying antirheumatic drugs (DMARDs). While joint inflammation is a known cause…
  • Abstract Number: 0814 • ACR Convergence 2025

    Pain Patterns in a Multicenter Randomized Trial of Early RA – Link Between Initially Sustained Joint Inflammation and Subsequent Non-inflammatory Pain Outcomes

    Annie Brink1, Johan Karlsson Wallman2, Jon T Einarsson1, Meliha Kapetanovic1, Elisabeth Mogard1, Elisabet Lindqvist1, Carmen Roseman1, Kristina Lend3, Merete Hetland4, Mikkel Ostergaard5, Kim Horslev-Petersen6, Dan Nordstrom7, Tuulikki Sokka-isler8, Bjorn Gudbjornsson9, Gerður María Gröndal9, Marte Heiberg10, Espen Haavardsholm10, Michael Nurmohamed11, Anna Rudin12, Ronald van Vollenhoven13, Till Uhlig10, Jon Lampa14 and Tor Olofsson2, 1Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden, 2Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, Skane Lan, Sweden, 3Department of Rheumatology and Amsterdam Rheumatology Center, Amsterdam University Medical Centers, Amsterdam; Department of Medicine, Rheumatology Unit, Center for Molecular Medicine (CMM), Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 4Copenhagen Center for Arthritis Research (COPECARE) and DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, 5Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, and Copenhagen Center for Arthritis Research, Center for Rheumatology, Rigshospitalet, Glostrup, Denmark, 6Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark, 7Division of Rheumatology, Helsinki University Hospital, Helsinki, Finland, 8Department of Medicine and University of Eastern Finland, Jyväskylä Central Hospital, Juväskylä, Finland, 9Landspitali University Hospital; Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 10Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, 11Amsterdam Rheumatology and Immunology Center, Reade; Department of Rheumatology and Amsterdam Rheumatology Center, Amsterdam University Medical Centers, Amsterdam, Netherlands, 12Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy of University of Gothenburg, Gothenburg, Sweden, 13Department of Rheumatology, Amsterdam University Medical Centre, Amsterdam, Netherlands, 14Department of Medicine, Rheumatology Unit, Center for Molecular Medicine (CMM), Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Emerging data indicate an uncoupling between pain and inflammation during the RA disease course, and comorbid fibromyalgia – thought to stem from central pain…
  • Abstract Number: 0317 • ACR Convergence 2025

    “No matter how great my doctor is, he hasn’t had a knee replacement, he doesn’t understand all that pain” Program Evaluation of the Moving Well Peer Coach Intervention for Total Knee Replacement

    Cara Murphy1, Sarah Young2, Vanessa Madrigal3, Noelia Hernandez4, Daniel Garcia5, Yuliana Dominguez Paez6, Monika Safford3, Iris Navarro-Millan7 and Mackenzie Brown8, 1HSS, New York, NY, 2Weill Cornell Medicine, Johnson City, NY, 3Weill Cornell Medicine, New York, 4Weill Cornell Medicine, New York, NY, 5Weill Cornell, Brooklyn, NY, 6Albert Einstein College of Medicine, The Bronx, NY, 7Weill Cornell Medicine, Hospital for Special Surgery, Poughkeepsie, NY, 8Weill Cornell Medicine, Brooklyn, NY

    Background/Purpose: Moving Well was a pre-habilitation peer coach intervention aimed at reducing levels of anxiety, depression, and pain among individuals undergoing total knee replacement (TKR)1.…
  • Abstract Number: 2623 • ACR Convergence 2025

    Disease Activity is a Novel Imaging Biomarker Associated with Knee Pain: Data from the Osteoarthritis Initiative

    Jeffrey Driban1, Jonggyu Baek2, Julieann Patarini2, Emily Kirillov3, Nhung Vo3, Michael Richard3, Ming Zhang4, Matthew Harkey5, Grace Lo6, Kate Lapane2, Shao-Hsien Liu2, Charles Eaton7, James Mackay8, Joshua Harvey2 and Timothy McAlington9, 1University of Massachusetts Chan Medical School, Marlborough, NH, 2UMass Chan Medical School, Worcester, MA, 3Tufts Medical Center, Boston, MA, 4Boston University, Westford, MA, 5Michigan State University, East Lansing, MI, 6Baylor College of Medicine / MEDVAMC, Houston, TX, 7Brown University, Pawtucket, RI, 8University of Cambridge; Norwich Medical School, San Diego, CA, 9UMass Chan School of Medicine, Arlington, MA

    Background/Purpose: Barriers to developing effective osteoarthritis (OA) therapies include the lack of standardized definitions for disease progression and structural endpoints that reliably predict changes in…
  • Abstract Number: 2085 • ACR Convergence 2025

    Estimating the Association between Effusion-synovitis and Knee Pain in a Subset of Participants with Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI)

    Dagoberto Robles1, Greg Gilles2, Nathaniel H. Christiansen3, Luke Grawer4, Karim Jayyusi4, Ali Shaikh4, Rongrong Tang5, Mihra S. Taljanovic4, Jeffrey Duryea6, Edward J. Bedrick5 and C. Kent Kwoh7, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, The University of Arizona College of Medicine, Tucson, AZ, 3University of Arizona, Stockton, NJ, 4University of Arizona, Tucson, 5The University of Arizona Arthritis Center, University of Arizona, Tucson, 6Brigham and Women’s Hospital, Boston, MA, 7The University of Arizona Arthritis Center, University of Arizona, Tucson, AZ

    Background/Purpose: Even though knee pain is ubiquitous in knee osteoarthritis (KOA) patients, currently there are limited treatment options which are only minimally or moderately efficacious…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 44
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology